论文部分内容阅读
依诺昔酮(enoximone)为新型的磷酸二酯酶Ⅲ抑制剂,兼有正性肌力和扩血管作用,能明显改善充血性心力衰竭患者的血流动力学,不良反应较少且易耐受,故是一种颇有前途的抗心衰药物。
Enoximone is a novel phosphodiesterase III inhibitor with both inotropic and vasodilator effects and significantly improves hemodynamics in patients with congestive heart failure with less adverse reactions and more susceptibility By, so it is a promising anti-heart failure drugs.